[{"address1": "1841 Page Mill Road", "address2": "Suite 100", "city": "Palo Alto", "state": "CA", "zip": "94304", "country": "United States", "phone": "(925) 247-4487", "website": "https://www.evommune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. It develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products includes EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.", "fullTimeEmployees": 45, "companyOfficers": [{"maxAge": 1, "name": "Mr. Luis C. Pena", "age": 61, "title": "Founder, President, CEO & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 928997, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kyle  Carver CPA, M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 733914, "exercisedValue": 0, "unexercisedValue": 2284}, {"maxAge": 1, "name": "Mr. Gregory S. Moss Esq.", "age": 40, "title": "Chief Business & Legal Officer, Corporate Secretary and Chief Compliance Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 750294, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eugene Andrew Bauer M.D.", "age": 82, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1942, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janice  Drew M.P.H.", "age": 62, "title": "Executive Vice President of Operations", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeegar  Patel Ph.D.", "age": 47, "title": "Chief Scientific Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lou  Sehl Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel J. Burge M.d.", "age": 62, "title": "Senior Vice President of Clinical Development", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 15.01, "open": 15.0, "dayLow": 15.295, "dayHigh": 19.4, "regularMarketPreviousClose": 15.01, "regularMarketOpen": 15.0, "regularMarketDayLow": 15.295, "regularMarketDayHigh": 19.4, "payoutRatio": 0.0, "forwardPE": -5.983607, "volume": 979713, "regularMarketVolume": 979713, "averageVolume": 205860, "averageVolume10days": 184780, "averageDailyVolume10Day": 184780, "bid": 17.0, "ask": 18.02, "bidSize": 200, "askSize": 200, "marketCap": 575314688, "fiftyTwoWeekLow": 13.885, "fiftyTwoWeekHigh": 24.03, "allTimeHigh": 24.03, "allTimeLow": 13.885, "priceToSalesTrailing12Months": 44.254974, "fiftyDayAverage": 19.103, "twoHundredDayAverage": 19.103, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 757021696, "profitMargins": 0.0, "floatShares": 15721696, "sharesOutstanding": 31524093, "sharesShort": 102787, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0037, "heldPercentInsiders": 0.12132, "heldPercentInstitutions": 0.39347, "shortRatio": 0.46, "shortPercentOfFloat": 0.0039, "impliedSharesOutstanding": 31524093, "bookValue": -117.776, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -62823000, "trailingEps": -2.09, "forwardEps": -3.05, "enterpriseToRevenue": 58.232, "enterpriseToEbitda": -10.605, "52WeekChange": -0.25803262, "SandP52WeekChange": 0.1340276, "quoteType": "EQUITY", "currentPrice": 18.25, "targetHighPrice": 42.0, "targetLowPrice": 36.0, "targetMeanPrice": 39.33333, "targetMedianPrice": 40.0, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 76062000, "totalCashPerShare": 2.413, "ebitda": -71386000, "totalDebt": 765000, "quickRatio": 7.302, "currentRatio": 7.867, "totalRevenue": 13000000, "debtToEquity": 1.036, "revenuePerShare": 8.456, "grossProfits": 13000000, "operatingCashflow": -78254000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1.3328, "financialCurrency": "USD", "symbol": "EVMN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1762439400000, "corporateActions": [], "postMarketTime": 1766192128, "regularMarketTime": 1766178003, "exchange": "NYQ", "messageBoardId": "finmb_695398216", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Evommune, Inc.", "regularMarketChangePercent": 21.5856, "regularMarketPrice": 18.25, "earningsTimestamp": 1765486800, "earningsTimestampStart": 1765486800, "earningsTimestampEnd": 1765486800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.09, "epsForward": -3.05, "epsCurrentYear": -8.12333, "priceEpsCurrentYear": -2.2466156, "fiftyDayAverageChange": -0.85300064, "fiftyDayAverageChangePercent": -0.044652704, "twoHundredDayAverageChange": -0.85300064, "twoHundredDayAverageChangePercent": -0.044652704, "priceToBook": -0.15495516, "sourceInterval": 15, "postMarketChangePercent": -2.2465744, "postMarketPrice": 17.84, "postMarketChange": -0.40999985, "regularMarketChange": 3.24, "regularMarketDayRange": "15.295 - 19.4", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 205860, "fiftyTwoWeekLowChange": 4.365, "fiftyTwoWeekLowChangePercent": 0.314368, "fiftyTwoWeekRange": "13.885 - 24.03", "fiftyTwoWeekHighChange": -5.7800007, "fiftyTwoWeekHighChangePercent": -0.2405327, "fiftyTwoWeekChangePercent": -25.803263, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Evommune", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]